scispace - formally typeset
E

E. Fileccia

Researcher at University of Bologna

Publications -  15
Citations -  249

E. Fileccia is an academic researcher from University of Bologna. The author has contributed to research in topics: Skin biopsy & Peripheral neuropathy. The author has an hindex of 6, co-authored 13 publications receiving 131 citations.

Papers
More filters
Journal ArticleDOI

In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.

TL;DR: In this article, the authors compared real-time quaking-induced conversion (RT-QuIC) and immunofluorescence (i.e., skin and CSF) for detecting misfolded α-synuclein in skin nerves.
Journal ArticleDOI

Skin Nerve Phosphorylated α-Synuclein Deposits in Parkinson Disease With Orthostatic Hypotension.

TL;DR: Patients with normal corrected Mini-Mental State Examination showed a wide involvement of p-syn deposits in autonomic cholinergic and adrenergic skin nerves compared with PD’s- OH, and patients with neurogenic OH showed a lower load of skin p- syn restricted to adrenergic fibers of SV still persisting over the follow-up period.
Journal ArticleDOI

Spine Topographical Distribution of Skin α-Synuclein Deposits in Idiopathic Parkinson Disease.

TL;DR: The data showed that cervical p-syn deposits displayed a uniform distribution between both sides not following the motor dysfunction in unilateral patients, and skin nerve p- syn deposits demonstrated a spine gradient with the cervical site expressing the highest positivity.
Journal ArticleDOI

Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy.

TL;DR: Skin Gb3 deposits are specific to FD patients with classical GLA mutations and are associated with lower skin innervation but they were not found inside axons, suggesting an indirect damage on peripheral small fibre innervation.
Journal ArticleDOI

Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.

TL;DR: Among all biomarkers, NfL yielded the highest diagnostic performance and was the best predictor of disease progression rate and survival in ALS and contribute to the understanding of the pathophysiological and electrophysiological correlates of biomarker changes.